Advertisement

ADVERTISEMENT

precision medicine

Trending From ACCC
Precision Medicine in Rural and Underserved Areas: Unique Solutions for Unique Challenges
12/19/2023
Rania Emara
Rania Emara explains the social barriers that socioeconomically affected rural groups experience with precision medicine and provides some insight into possible solutions.
Rania Emara explains the social barriers that socioeconomically affected rural groups experience with precision medicine and provides some insight into possible solutions.
Rania Emara explains the social...
12/19/2023
Journal of Clinical Pathways
News
Utility of Genomic Instability Test Scores for Predicting PARP Response in Ovarian Cancer
06/03/2020
HRD test results used in published and ongoing clinical trials for PARP inhibitor-treatment of ovarian cancer are not equivalent, according to the results of a study presented at the American Society of Clinical...
HRD test results used in published and ongoing clinical trials for PARP inhibitor-treatment of ovarian cancer are not equivalent, according to the results of a study presented at the American Society of Clinical...
HRD...
06/03/2020
Journal of Clinical Pathways
Prior Authorization for Comprehensive Genomic Profiling in Clinical Pathways
Interview
Prior Authorization for Comprehensive Genomic Profiling in Clinical Pathways
05/27/2020
At the Community Oncology Alliance (COA) Annual Meeting (April 24, 2020), Lee Schwartzberg, MD, FACP, West Cancer Center and Research Institute (a member of OneOncology), moderated a stakeholder panel discussion on...
At the Community Oncology Alliance (COA) Annual Meeting (April 24, 2020), Lee Schwartzberg, MD, FACP, West Cancer Center and Research Institute (a member of OneOncology), moderated a stakeholder panel discussion on...
At the...
05/27/2020
Journal of Clinical Pathways
Payer Perceptions of Genomic Precision Medicine
Healthcare Economist
Payer Perceptions of Genomic Precision Medicine
05/20/2020

Jason Shafrin, PhD

Jason Shafrin, PhD
Jason Shafrin, PhD, highlights a study that shows which factors payers consider when evaluating whether to provide coverage for genetic tests as well as how they value these factors.
Jason Shafrin, PhD, highlights a study that shows which factors payers consider when evaluating whether to provide coverage for genetic tests as well as how they value these factors.
Jason Shafrin, PhD, highlights a...
05/20/2020
Journal of Clinical Pathways
Research in Review
Panel Highlights Uses of Genomic Testing for Breast Cancer
06/07/2017
JCP Editors
A panel of breast cancer experts offered an education session on the value of standard and genomic testing for breast cancer at the 2017 American Society of Clinical Oncology Annual Meeting (June 2-6, 2017; Chicago,...
A panel of breast cancer experts offered an education session on the value of standard and genomic testing for breast cancer at the 2017 American Society of Clinical Oncology Annual Meeting (June 2-6, 2017; Chicago,...
A...
06/07/2017
Journal of Clinical Pathways
Research in Review
Financial Benefit of NGS Varies by Patient, Disease Type in Community Settings
06/01/2017
JCP Editors
Next-generation sequencing (NGS) may be economically beneficial for select patients with treated in the community oncology setting, but it should be carefully applied due to potential associated financial burdens,...
Next-generation sequencing (NGS) may be economically beneficial for select patients with treated in the community oncology setting, but it should be carefully applied due to potential associated financial burdens,...
...
06/01/2017
Journal of Clinical Pathways
Research in Review
Microbiome Signature Helps Predict Prostate Cancer
06/01/2017
JCP Editors
Transcriptome sequencing that identifies pathogens in prostate cancer biopsies can be used as a signature for disease detection, according to research presented at the 2017 ASCO Annual Meeting (June 2-6, 2017;...
Transcriptome sequencing that identifies pathogens in prostate cancer biopsies can be used as a signature for disease detection, according to research presented at the 2017 ASCO Annual Meeting (June 2-6, 2017;...
...
06/01/2017
Journal of Clinical Pathways
Research in Review
New NGS Platform Better Identifies Targetable Genomic Alterations in Metastatic Cancers
05/31/2017
JCP Editors
A new comprehensive next generation sequencing (NGS) platform is more likely than targeted NGS platforms to identify clinically relevant and actionable molecular alterations in metastatic cancers, according to...
A new comprehensive next generation sequencing (NGS) platform is more likely than targeted NGS platforms to identify clinically relevant and actionable molecular alterations in metastatic cancers, according to...
A new...
05/31/2017
Journal of Clinical Pathways
Research in Review
Genomic Analyses Guide Targeted Therapies for Metastatic Cancers
04/07/2017
JCP Editors
High-throughput genomic analyses may improve outcomes in patients with types of metastatic cancer, according to results of a recent trial published in Cancer Discovery (published online April 1, 2017;...
High-throughput genomic analyses may improve outcomes in patients with types of metastatic cancer, according to results of a recent trial published in Cancer Discovery (published online April 1, 2017;...
...
04/07/2017
Journal of Clinical Pathways
Research in Review
Rare Form of Colorectal Cancer Responds Well to Precision Medicine
04/06/2017
JCP Editors
Patients with a specific type of metastatic colorectal cancer who are chemotherapy-resistant benefit from treatment with a gene-targeting regimen. ----- Related Content ESMO announces changes to metastatic...
Patients with a specific type of metastatic colorectal cancer who are chemotherapy-resistant benefit from treatment with a gene-targeting regimen. ----- Related Content ESMO announces changes to metastatic...
...
04/06/2017
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

Psych Congress Regionals
July 18 ⁠–⁠ July 19
Advances in Inflammatory Bowel Disease Regionals
July 19 ⁠–⁠ July 20
July 24 ⁠–⁠ July 26
APP Institute Inflammatory Bowel Disease
July 26 ⁠–⁠ July 27
July 27 ⁠–⁠ July 28
July 27 ⁠–⁠ July 28
Psych Congress Regionals
August 8 ⁠–⁠ August 9
August 14 ⁠–⁠ August 17
APP Institute Dermatology
August 16 ⁠–⁠ August 17
August 16 ⁠–⁠ August 18
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use